Back

Catecholaminergic polymorphic ventricular tachycardia: is gene therapy the holy grail?

28 August 2026 (11:30 - 11:45)
Organised by: Logo
Congress Presentation Part of: Latest advances in primary arrhythmias beyond the ESC Guidelines Arrhythmias, General ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Silvia Giuliana Priori

University of Pavia, Pavia (Italy)

3 More presentations in this session

Presentation thumbnail
ECG and artificial intelligence in the prediction of cardiac arrest
Professor E. Behr (London, GB)
Slides Video
Presentation thumbnail
Long QT syndrome: should we use mexiletine in all long QT syndrome type 2? and how?
Professor J. Tfelt-Hansen (Copenhagen, DK)
Slides Video
Presentation thumbnail
Latest advances in primary arrhythmias beyond the ESC Guidelines - discussion
Video

Access the full session

Session thumbnail
Latest advances in primary arrhythmias beyond the ESC Guidelines
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 11:30 CET
You may be interested in
thumbnail
Congress Presentation
Gene therapies for inherited channelopathies
31 August 2024
thumbnail
Congress Presentation
From pre-participation screening to familial diagnosis: detecting catecholaminergic polymorphic ventricular tachycardia
4 April 2025
thumbnail
Congress Presentation
State-of-the-art lecture on ventricular arrhythmias: enhancing treatment strategies and clinical outcomes
28 August 2026
thumbnail
Congress Presentation
Overexpression of cardiac calsequestrin as a novel gene-therapy approach to treat CPVT1: in silico and in vivo proves of principle.
25 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources